Additional Professor
Verified email at
Cited by
Cited by
Nonadherence to imatinib adversely affects event free survival in chronic phase chronic myeloid leukemia
P Ganesan, TG Sagar, B Dubashi, R Rajendranath, K Kannan, S Cyriac, ...
American journal of hematology 86 (6), 471-474, 2011
Clinicopathological analysis and outcome of primary mediastinal malignancies—a report of 91 cases from a single institute
B Dubashi, S Cyriac, SG Tenali
Annals of thoracic medicine 4 (3), 140, 2009
Quality of life among young women with breast cancer: Study from a tertiary cancer institute in south India
B Dubashi, E Vidhubala, S Cyriac, TG Sagar
Indian journal of cancer 47 (2), 142, 2010
Pharmacogenetics of methotrexate in acute lymphoblastic leukaemia: why still at the bench level?
S Kodidela, PS Chandra, B Dubashi
European journal of clinical pharmacology 70 (3), 253-260, 2014
Rituximab induced myocardial infarction: a fatal drug reaction
P Arunprasath, P Gobu, B Dubashi, S Satheesh, J Balachander
Journal of Cancer Research and Therapeutics 7 (3), 346, 2011
Clinical presentation and outcome of pediatric ovarian germ cell tumor: a study of 40 patients
D Biswajit, CN Patil, TG Sagar
Journal of pediatric hematology/oncology 32 (2), e54-e56, 2010
Influence of dihydrofolate reductase gene polymorphisms rs408626 (-317A> G) and rs442767 (-680C> A) on the outcome of methotrexate-based maintenance therapy in South Indian …
S Kodidela, SC Pradhan, B Dubashi, D Basu
European journal of clinical pharmacology 71 (11), 1349-1358, 2015
Trough concentration and ABCG2 polymorphism are better to predict imatinib response in chronic myeloid leukemia: a meta-analysis
ZP Jiang, XL Zhao, N Takahashi, S Angelini, B Dubashi, L Sun, P Xu
Pharmacogenomics 18 (1), 35-56, 2017
Influence of Sokal, Hasford, EUTOS scores and pharmacogenetic factors on the complete cytogenetic response at 1 year in chronic myeloid leukemia patients treated with imatinib
J Francis, B Dubashi, R Sundaram, SC Pradhan, A Chandrasekaran
Medical Oncology 32 (8), 213, 2015
Prescription errors in cancer chemotherapy: Omissions supersede potentially harmful errors
J Mathaiyan, T Jain, B Dubashi, KS Reddy, G Batmanabane
Journal of pharmacology & pharmacotherapeutics 6 (2), 83, 2015
A study to explore the correlation of ABCB1, ABCG2, OCT1 genetic polymorphisms and trough level concentration with imatinib mesylate-induced …
J Francis, B Dubashi, R Sundaram, SC Pradhan, A Chandrasekaran
Cancer chemotherapy and pharmacology 76 (6), 1185-1189, 2015
A rare case of adult acute lymphoblastic leukemia presenting with paraparesis and multiple osteolytic lesions
SP Verma, B Dubashi, D Basu, TK Dutta, R Kar
Indian Journal of Hematology and Blood Transfusion 30 (1), 24-26, 2014
Docetaxel-induced hand foot syndrome:" No dose is a safe dose".
A Jain, B Dubashi
Journal of Pharmacology & Pharmacotherapeutics 3 (2), 2012
Mesentric gastrointestinal stromal tumor with bone metastases
A Jain, B Dubashi, S Chandra, D Halanaik
Indian Journal of Cancer 48 (3), 383, 2011
Weekly paclitaxel in ovarian cancer—the latest success story
A Jain, B Dubashi, KS Reddy, P Jain
Current Oncology 18 (1), 16, 2011
Prescription, transcription and administration errors in out-patient day care unit of a regional cancer centre in South India
J Mathaiyan, T Jain, B Dubashi, G Batmanabane
Asian Pacific Journal of Cancer Prevention 17 (5), 2611-2617, 2016
Philadelphia chromosome positive pre-T cell acute lymphoblastic leukemia: a rare case report and short review
SP Verrma, TK Dutta, KV Vinod, B Dubashi, KK Ariga
Indian Journal of Hematology and Blood Transfusion 30 (1), 177-179, 2014
Cefepime vs. cefoperazone/sulbactam in combination with amikacin as empirical antibiotic therapy in febrile neutropenia
M Ponraj, B Dubashi, BH Harish, S Kayal, SL Cyriac, J Pattnaik, K Ranjith, ...
Supportive Care in Cancer 26 (11), 3899-3908, 2018
Chemotherapy induced adverse drug reactions in cancer patients in a tertiary care hospital in south India
SK Behera, CR Kishtapati, V Gunaseelan, B Dubashi, A Chandrasekaran, ...
Journal of Young Pharmacists 9 (4), 593, 2017
Tumor lysis syndrome in multiple myeloma treated with bortezomib
KM Dhanraj, D Biswajit
Journal of pharmacology & pharmacotherapeutics 5 (2), 161, 2014
The system can't perform the operation now. Try again later.
Articles 1–20